This podcast takes a close look at the risk factors for prostate cancer, the second leading cause of cancer deaths in the U.S. Our guest is Paul Arangua, MPH in Epidemiology and an educator/researcher with the Prostate Conditions Education Council. We explore the incidence of prostate cancer, the risk factors, screening recommendations, and treatment outcomes. Why is prostate cancer so virulent? When left untreated, why does it spread so rapidly to other tissue and organs in the body? What is the survival rate when caught early? And, what is the relatively high mortality rate if left unidentified and localized in the body? Our guest shares PSA screening recommendations for different age groups, as well as newer screens using genomic markers. What lifestyle changes are closely aligned with prevention? This is a highly educational and must-know topic for all men, and partners. Be sure to tune in.

Mini Bio

Paul Arangua MPH is an accomplished public health professional, specializing in prostate cancer and men’s health. With a strong background in clinical environments, Paul has navigated various aspects of prostate cancer, from screening to 3D diagnostics, innovative focal therapies and disease progression.

His expertise spans over 17 years, working alongside Dr. E. David Crawford conducting research in clinical epidemiology, medical device proof-of-concept, FDA regulatory strategy, and health administration. Paul has played key roles in startups like Triopsy Medical, showcasing leadership in research, product development, and engineering design for cutting-edge technologies in prostate cancer diagnosis. Beyond his professional work, he actively engages in educational initiatives and patient advocacy. He serves as the Director of Research and Patient Insights at the Prostate Conditions Education Council.

Paul has taken part in numerous speaking engagements, abstracts, and publications, highlighting his commitment to research and knowledge-sharing within the medical community. Covering topics from innovative biomarkers to novel diagnostic algorithms, his extensive skill set in data management, research, project management, and patient education underscores his dedication to advancing prostate cancer research and promoting men’s health awareness.

For Our Listeners

Prostate Conditions Education Council